0.10
0.00%
Close of 9 Nov 2026, in CAD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Aurora Spine
Its shares trade on TSX Venture under the ticker ASG.V. It has been listed since 10 September 2013. In the fiscal year to 31 December 2025, it reported revenue of $18.4m and a net loss of $731,120. At that date it held total assets of $10.4m and shareholders' equity of $3.8m.
Aurora Spine Corp. develops and distributes spinal implant products in Canada. The company is headquartered in Toronto, Ontario. The company went IPO on 2013-09-10. The firm's segment includes its focus on the development and sale of minimally invasive, interspinous fusion systems and devices. The firm's interspinous process (ISP) lumbar fusion devices include the ZIP and ZIP ULTRA, the ZIP LP and the ZIP-51. In addition, the Company offers a line of interbody products, such as the TiNano product line, including EOS, Echo and EchoXL for the lumbar section of the spine, and discovery for cervical procedures. Its product lines include ISP lumbar fusion devices; polyether ether ketone (PEEK) interbody cages, and Stand-alone (SA) Cervical and Lumbar devices. Its interbody cage products are used to fill the space between vertebrae after degenerative disc material has been removed. Its VOX is a minimally invasive lateral lumbar interbody fusion (LLIF) system featuring TiNano titanium spray coating technology. The company characterizes business in the United States and outside the United States.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 10 Sept 2013
- Employees
- 13
- Website
- auroraspine.us ↗
Leadership
Pay as last reported
- Mr. David RosenkrantzIndependent Chairman of the Board$20,278
- Mr. Trent NorthcuttPresident, Chief Executive Officer, Director, since 2012$207,626
- Mr. Chad ClouseChief Financial Officer$166,626
- Mr. Tracy GrafIndependent Director$2,023
- Mr. J. Daryl MaclellanIndependent Director$1,977
- Mr. Michael SeidIndependent Director$1,734
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Aurora Spine Corp boasts a strong portfolio of innovative spinal implant technologies. Their products are designed to address various spinal disorders and offer advanced solutions for patients seeking improved quality of life.
- The company holds a robust IP portfolio with several patents and trademarks in the spinal implant industry. This enables them to protect their proprietary technologies and maintain a competitive edge against potential rivals.
- Aurora Spine Corp is led by a seasoned management team with extensive industry experience. Their collective expertise allows them to effectively navigate the challenges of the healthcare sector and drive the company's growth strategies.
Weaknesses
- The company's market reach is relatively limited, primarily focusing on specific regions or countries. This can hinder their growth potential, as they may miss out on opportunities in untapped markets or face increased competition in concentrated markets.
- Aurora Spine Corp relies on a few key suppliers for critical components of their products. Any disruption in the supply chain or issues with these suppliers could negatively impact the company's manufacturing processes, leading to delays or quality concerns.
- Being in the healthcare industry, Aurora Spine Corp must comply with stringent regulatory requirements for their products. The evolving nature of regulations and the time-consuming approval processes can pose challenges and delays in introducing new products to the market.
Opportunities
- The global population is increasingly aging, leading to a rise in spinal disorders and related surgeries. Aurora Spine Corp can capitalize on this demographic trend by expanding their product offerings and penetrating deeper into the market to meet the growing demand for spinal implant solutions.
- Rapid advancements in medical technology present opportunities for Aurora Spine Corp to develop and introduce newer, more efficient spinal implant products. Staying at the forefront of technological trends can give the company a competitive advantage and attract healthcare professionals and patients alike.
- Forming strategic partnerships with hospitals, clinics, and other healthcare organizations can provide Aurora Spine Corp with enhanced market access, distribution channels, and collaborative research opportunities. Partnerships can help the company expand its footprint and reach a wider customer base.
Threats
- The spinal implant industry is highly competitive, with numerous established players and emerging startups vying for market share. Aurora Spine Corp needs to continuously innovate and differentiate their products to withstand competition and retain their market position.
- Fluctuations in the global economy can impact healthcare spending and demand for medical devices. Economic downturns or financial crises can potentially lead to reduced funding for surgeries or delayed adoption of new technologies, posing a threat to Aurora Spine Corp's revenues.
- As a manufacturer of medical devices, Aurora Spine Corp faces the risk of product liability claims or recalls. Any defects, failures, or adverse events associated with their spinal implant products could result in legal disputes, reputational damage, and financial losses.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.